The analysis of the clinicopathological characteristics of a patient cohort showed that ROS1-positive patients, with an incidence of 1,7%, integrate a genetic subtype of NSCLC with similar characteristics to ALK-positive patients [63]. This evidence concerns the gene ROS1 and non-small cell lung carcinoma.